PREVALENCE OF HIGH CARCINOGENIC RISK HUMAN PAPILLOMAVIRUS IN THE REPUBLIC OF SAKHA (YAKUTIA), ST. PETERSBURG AND THE REPUBLIC OF KARELIA
Abstract
Results of the study in three regions of the Russian Federation have shown widespread of high carcinogenic human papillomavirus among patients of dermatovenerological and gynecological profile. Detection of viral DNA in the material from the cervix and urethra ranged from 25,2 (Karelia) to 42,5 (Sakha Republic (Yakutia) per 100 examined patients. In all areas in 2010-2011 first place was occupied by 16-th virus genotype - from 11,5 (Sakha Republic (Yakutia) to 15,9 (St. Petersburg) per 100 patients. Prevalence of 11 other types differs. In the Sakha Republic (Yakutia) the second rank place was occupied by types 31 and. 51 (8,0 per 100 examined patients), in St. Petersburg - by 56 and 31 types (9,7 and. 7,6 per 100 patients). Age risk group contains patients of the age of 20-29 years. Information on circulating genotypes of the virus is a necessary part of surveillance to validate vaccination against human papillomavirus infection and evaluation of its efficiency.
About the Authors
L. V. Lyalina
Saint-Petersburg Pasteur Institute
Russian Federation
Russian Federation
M. E. Ignatyeva
Saint-Petersburg Department of Federal Service for Consumer Rights Protection and Human Welfare of the Sakha Republic (Yakutia) ; Saint-Petersburg Pasteur Institute
Russian Federation
Russian Federation
O. V. Narvskaya
Saint-Petersburg Pasteur Institute
Russian Federation
Russian Federation
Yu. N. Filippova
Всероссийский центр экстренной и радиационной медицины им. А.И. Никифорова МЧС России
Russian Federation
Russian Federation
A. A. Vyazovaya
Saint-Petersburg Pasteur Institute
Russian Federation
Russian Federation
E. V. Kasatkin
Saint-Petersburg Dermatovenerologic Dispensary № 8
Russian Federation
Russian Federation
E. V. Katkyavichene
Saint-Petersburg Dermatovenerologic Dispensary of the Karelia Republic
Russian Federation
Russian Federation
References
1. Киселев В.И. Вирусы папилломы человека в развитии рака шейки матки. - М.: «Димитрейд График Групп», 2004. - 184 с.
2. Медицинские и социальные аспекты профилактики папилломавирусной инфекции и ассоциированных с ней злокачественных новообразований / Л.В. Лялина [и др.] // Эпидемиология и вакцинопрофилактика. - 2005. - № 3 (22). -С. 31-34.
3. Папилломавирусная инфекция: диагностика, лечение и профилактика: пособие для врачей / В.Н. Прилепская [и др.]. - М.: «МЕДпресс-информ», 2007. - 32 с.
4. Сафронникова Н.Р., Мерабишвили В.М. Профилактика вирусозависимых онкологических заболеваний. Диагностика и лечение папилломавирусной инфекции: пособие для врачей. - СПб., 2006. - 48 с.
5. Цервикальный скрининг в России: пути повышения его эффективности / О.Ю. Шипулина [и др.] // Папилломавирусная инфекция и рак. Интегрированная система надзора и профилактики: материалы II симпозиума с международным участием, Санкт-Петербург, 7 - 9 июня 2011 г. -СПб., 2011. - С. 55 - 59.
6. Cancer Research for Cancer Control // International Agency for Research on Cancer WHO. -Lyon, 2001. - 35 p.
7. Donovan B. Quadrivalent human papillomavirus vaccination and trends in genital warts in Australia: analysis of national sentinel surveillance data / B. Donovan [et al.] // Lancet Infect. Dis. - 2011. - Vol. 11. - P. 39 - 44.
8. Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24 - 45 years: a randomized, double-blind trial / N. Munoz [et al.] // Lancet. - 2009. - Vol. 373. - P. 1949-1957.
9. Stanley M. A Practitioners Guide to Understanding Immunity to Human Papillomavirus // US Obstetrics & Gynecology. - 2009. - Vol. 4 (1). -P. 10-15.
10. The causal relation between human papillomavirus and cervical cancer / F.X. Bosch [et al.] // J. Clin. Pathology. - 2002. - Vol. 55. -P. 244 - 265.
11. Zur Hausen H. Papillomaviruses in anogenital cancer as a model to understand the role of viruses in human cancer // Cancer Res. - 1989. - Vol. 49. -P. 4677 - 4681.
Review
For citations:
Lyalina L.V., Ignatyeva M.E., Narvskaya O.V., Filippova Yu.N., Vyazovaya A.A., Kasatkin E.V., Katkyavichene E.V. PREVALENCE OF HIGH CARCINOGENIC RISK HUMAN PAPILLOMAVIRUS IN THE REPUBLIC OF SAKHA (YAKUTIA), ST. PETERSBURG AND THE REPUBLIC OF KARELIA. Acta Biomedica Scientifica. 2012;(5(1)):68-71. (In Russ.)
Views:
480
.png)
Email this article 
